請輸入關鍵字
top
YH002
2020.06.30

藥物名稱:YH002(OX40)

階段:臨床I期

適應癥:實體瘤


開展地區:澳大利亞

試驗名稱:A First-in-Human (FIH), Multicenter, Open-Label, Phase 1 Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of YH002 in Subjects with Advanced Solid Malignancies

試驗鏈接:https://clinicaltrials.gov/ct2/show/NCT04353102